Incidence and complications of perioperative atrial fibrillation after non-cardiac surgery for malignancy.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
30
12
2018
accepted:
16
04
2019
entrez:
8
5
2019
pubmed:
8
5
2019
medline:
15
1
2020
Statut:
epublish
Résumé
Perioperative atrial fibrillation (POAF) is one of the common arrhythmias in the setting of non-cardiac surgeries for malignancy. As POAF may cause subsequent adverse events, it is important to confirm its characteristics and risk factors. The prospective cohort study of surveillance for perioperative atrial fibrillation recurrence (PREDICT AF RECURRENCE) is an ongoing prospective, single-center, observational study that aims to illustrate the clinical impact of POAF in major non-cardiac surgery for malignancy. Patients who planned to undergo non-cardiac surgery for definitive/suspected malignancy were registered. Those with a history of AF and atrial flutter were excluded. Any 30-day complications included acute myocardial infarction, congestive heart failure, bleeding, thrombosis, any infection, and acute kidney injury. The primary endpoint was an incidence of POAF. The present study included 799 patients (age, 68 ± 11; male, 62%). Of these, 80 patients (10.0%) developed POAF. Notably, 66 patients (83%) had no symptoms. Any 30-day complications occurred in 180 patients (23%) (with POAF: 34 (43%); without POAF: 146 (20%); p < 0.001). POAF in 17 patients (50%) was preceded by the development of complications. No patient developed cardiogenic shock and/or acute heart failure. The association between 30-day complications and POAF development were analyzed using the multivariate adjusted model (odds ratio: 2.84; 95% confidence interval: 1.74-4.62; p < 0.001). Ten percent of patients who underwent non-cardiac surgery for malignancy developed POAF, which was strongly associated with perioperative complications. As a majority were asymptomatic, careful observation using electrocardiography monitoring is important to avoid oversights. UMIN ID: UMIN000016146.
Sections du résumé
BACKGROUND
Perioperative atrial fibrillation (POAF) is one of the common arrhythmias in the setting of non-cardiac surgeries for malignancy. As POAF may cause subsequent adverse events, it is important to confirm its characteristics and risk factors.
MATERIALS AND METHODS
The prospective cohort study of surveillance for perioperative atrial fibrillation recurrence (PREDICT AF RECURRENCE) is an ongoing prospective, single-center, observational study that aims to illustrate the clinical impact of POAF in major non-cardiac surgery for malignancy. Patients who planned to undergo non-cardiac surgery for definitive/suspected malignancy were registered. Those with a history of AF and atrial flutter were excluded. Any 30-day complications included acute myocardial infarction, congestive heart failure, bleeding, thrombosis, any infection, and acute kidney injury. The primary endpoint was an incidence of POAF.
RESULTS
The present study included 799 patients (age, 68 ± 11; male, 62%). Of these, 80 patients (10.0%) developed POAF. Notably, 66 patients (83%) had no symptoms. Any 30-day complications occurred in 180 patients (23%) (with POAF: 34 (43%); without POAF: 146 (20%); p < 0.001). POAF in 17 patients (50%) was preceded by the development of complications. No patient developed cardiogenic shock and/or acute heart failure. The association between 30-day complications and POAF development were analyzed using the multivariate adjusted model (odds ratio: 2.84; 95% confidence interval: 1.74-4.62; p < 0.001).
CONCLUSION
Ten percent of patients who underwent non-cardiac surgery for malignancy developed POAF, which was strongly associated with perioperative complications. As a majority were asymptomatic, careful observation using electrocardiography monitoring is important to avoid oversights.
CLINICAL TRIAL REGISTRATION
UMIN ID: UMIN000016146.
Identifiants
pubmed: 31063466
doi: 10.1371/journal.pone.0216239
pii: PONE-D-18-37073
pmc: PMC6504100
doi:
Banques de données
UMIN-CTR
['UMIN000016146']
Types de publication
Clinical Trial
Journal Article
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0216239Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Ann R Coll Surg Engl. 2001 May;83(3):174-6
pubmed: 11432135
J Am Coll Cardiol. 2018 Oct 30;72(18):2231-2264
pubmed: 30153967
Am Heart J. 2000 Dec;140(6):878-85
pubmed: 11099991
Circ Res. 2014 Apr 25;114(9):1500-15
pubmed: 24763467
Am J Cardiol. 2015 Apr 15;115(8):1090-4
pubmed: 25711434
Circulation. 2003 Jun 17;107(23):2920-5
pubmed: 12771006
Eur Heart J. 1999 May;20(10):748-54
pubmed: 10329066
Heart. 2001 Nov;86(5):527-32
pubmed: 11602545
N Engl J Med. 2008 Jun 19;358(25):2667-77
pubmed: 18565859
J Am Coll Cardiol. 1992 Sep;20(3):527-32
pubmed: 1512329
N Engl J Med. 2018 Feb 01;378(5):417-427
pubmed: 29385358
BMC Cardiovasc Disord. 2018 Jun 26;18(1):127
pubmed: 29940875
JAMA. 2014 Aug 13;312(6):616-22
pubmed: 25117130
Ann Palliat Med. 2018 Apr;7(2):265-273
pubmed: 29307210
Eur Heart J. 2012 Jun;33(12):1500-10
pubmed: 22246443
J Am Coll Cardiol. 1998 Sep;32(3):695-703
pubmed: 9741514
Blood. 2013 Oct 3;122(14):2310-7
pubmed: 23843493
J Am Coll Cardiol. 2018 Oct 23;72(17):2027-2036
pubmed: 30336826
Crit Care. 2007;11(2):R31
pubmed: 17331245
Eur J Heart Fail. 2009 Jul;11(7):676-83
pubmed: 19553398
Intern Emerg Med. 2012 Oct;7(5):431-8
pubmed: 21968511